USPTO serial 87811542
BIOLAB FARMACÊUTICA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOLAB FARMACÊUTICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Melissa A. Nowak
Melissa A. Nowak CHRISTENSEN O'CONNOR JOHNSON KINDNESS1201 THIRD AVENUE, SUITE 3600SEATTLE, WA 98101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetic preparations; cosmetic products for skincare, namely, facial cleaning preparations, acne foam cleansers and moisturizers, not for medical purposes; cosmetic preparations for sun protection; hair lotions; preparations for nail care; facial soaps; toilet products, namely, moisturizing preparations for the skin | ACTIVE | — |
| 005 | Medicines for human and veterinary use in the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; adjuvants for medical purposes; pharmaceutical preparations for human and veterinary use for the treatment and prevention of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; chemical-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional complements in the nature of nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic food, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOLAB SANUS FARMACÊUTICA LTDA.
- Other trademarks owned by BIOLAB SANUS FARMACÊUTICA LTDA.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named BIOLAB FARMACÊUTICA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 18, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 18, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 26, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 25, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 25, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 10, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 10, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 8, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 4, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 4, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 9, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 9, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 9, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 30, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 28, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 28, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 28, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 11, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 9, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 9, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 9, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 11, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 6, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 5, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 1, 2018 | NWAP | NEW APPLICATION ENTERED | — |